Viewing Study NCT02189603


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2026-05-19 @ 11:02 PM
Study NCT ID: NCT02189603
Status: COMPLETED
Last Update Posted: 2018-08-17
First Post: 2014-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®)
Sponsor: Jun Zhang
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis E View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hepatitis E View
None Immunogenicity View
None vaccine View
None safety View